Plasma post-heparin lipolytic activity in patients with malabsorption: effect of intravenous fat administration.
D000328:Adult; D000368:Aged; D002446:Celiac Disease / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D003059:Cocos; D004338:Drug Combinations; D005227:Fatty Acids / Q000032:analysis; D005260:Female; D005990:Glycerol / Q000008:administration & dosage*; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D006868:Hydrolysis; D007263:Infusions, Parenteral; D007421:Intestine, Small / Q000378:metabolism; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008079:Lipoproteins, VLDL / Q000032:analysis; D008286:Malabsorption Syndromes / Q000097:blood / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009821:Oils / Q000008:administration & dosage*; D010713:Phosphatidylcholines / Q000008:administration & dosage*; D012965:Sodium Chloride / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood; D014304:Triolein
D004338:Drug Combinations; D005227:Fatty Acids; D008055:Lipids; D008079:Lipoproteins, VLDL; D009821:Oils; D010713:Phosphatidylcholines; D014280:Triglycerides; D014304:Triolein; D012965:Sodium Chloride; D006493:Heparin; D002784:Cholesterol; D005990:Glycerol